- Home
- CGTX vs CJET Comparison
CGTX vs CJET Comparison
Compare CGTX & CJET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CGTX
- CJET
- Stock Information
- Founded
- CGTX 2007
- CJET 2009
- Country
- CGTX United States
- CJET China
- Employees
- CGTX 25
- CJET N/A
- Industry
- CGTX Biotechnology: Pharmaceutical Preparations
- CJET Auto Manufacturing
- Sector
- CGTX Health Care
- CJET Consumer Discretionary
- Exchange
- CGTX Nasdaq
- CJET Nasdaq
- Market Cap
- CGTX 53.4M
- CJET 50.7M
- IPO Year
- CGTX 2021
- CJET N/A
- Fundamental
- Price
- CGTX $0.84
- CJET $2.62
- Analyst Decision
- CGTX Strong Buy
- CJET
- Analyst Count
- CGTX 4
- CJET 0
- Target Price
- CGTX $2.83
- CJET N/A
- AVG Volume (30 Days)
- CGTX 19.4M
- CJET 10.5K
- Earning Date
- CGTX 08-07-2025
- CJET 08-05-2025
- Dividend Yield
- CGTX N/A
- CJET N/A
- EPS Growth
- CGTX N/A
- CJET N/A
- EPS
- CGTX N/A
- CJET N/A
- Revenue
- CGTX N/A
- CJET $6,915,000.00
- Revenue This Year
- CGTX N/A
- CJET N/A
- Revenue Next Year
- CGTX N/A
- CJET N/A
- P/E Ratio
- CGTX N/A
- CJET N/A
- Revenue Growth
- CGTX N/A
- CJET N/A
- 52 Week Low
- CGTX $0.22
- CJET $1.09
- 52 Week High
- CGTX $2.54
- CJET $4.41
- Technical
- Relative Strength Index (RSI)
- CGTX 72.32
- CJET 59.90
- Support Level
- CGTX $0.55
- CJET $2.27
- Resistance Level
- CGTX $0.87
- CJET $2.77
- Average True Range (ATR)
- CGTX 0.10
- CJET 0.30
- MACD
- CGTX 0.02
- CJET 0.01
- Stochastic Oscillator
- CGTX 61.76
- CJET 74.58
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.
About CJET Chijet Motor Company Inc.
Chijet Motor Co Inc is engaged in the development, manufacture, sales, and service of new energy vehicles (NEV), hybrid vehicles and traditional fuel vehicles in China. New energy vehicles refer to plug-in electric vehicles, including battery electric vehicles, plug-in hybrid (PHEV) electric vehicles, and fuel cell electric vehicles. Its passenger vehicles include small cars, sedans, and sports utility vehicles, or SUVs, and commercial vehicles include light trucks and vans. The company generates all of its revenue from PRC.